The Reality: Biology is getting heavy

Riaan, I’ve been following the TAPS+ launch and the new Visby partnership. Moving from standard DNA-seq to multimodal is a massive technical leap. But we both know the "physics" of that leap: Data Gravity. TAPS+ generates 2-3x the data per run. Visby pushes you from the lab to the "Edge" (IoT). You are essentially transitioning from a "Reagent Company" to a "Data Company," and that means your compute usage is about to decouple from your headcount.

The "Vacancy Tax"

I see you are hiring a Bioinformatics Cloud Engineer. I know exactly who you are looking for: Someone who understands Nextflow pipelines and AWS cost allocation and spot instance orchestration. That unicorn is hard to find. In the meantime, you are paying a "Vacancy Tax." You are likely stuck maintaining the AWS Batch environment or debugging ECR container pulls instead of focusing on the TAPS+ commercial rollout. You are burning expensive "Systems Thinking" hours on plumbing.

The Fix: We handle the Batch, you handle the Biology

Think of 2bcloud as your "Fractional Cloud Team" that bridges the gap while you hire. We don't touch the genomic science. We simply ensure the AWS Batch environment running it is bulletproof. We handle the heavy lifting, optimizing the Nextflow head nodes and automating the Spot Instance interruptions, so your pipelines just run.

The "Funded" Offensive

Since you raised that Series A back in 2022, extending runway is critical. But here is the "Offensive" play: AWS has specific buckets of money for "HPC & Genomics" scale-ups. As a Premier Partner, I can help you weaponize these funds. We don't just "save you money", we get AWS to pay for the architecture modernization needed for the Visby integration. We use their cash to build your future infrastructure.

What We Take Off Your Plate:

·        Spot Instance Strategy: TAPS+ requires massive compute. We configure AWS Batch to run on Spot Instances (90% cheaper) with automated retry logic, so you don't overpay for sequencing runs.

·        S3 Lifecycle: You have petabytes of historical genomic data. We automate the movement to "Glacier Deep Archive" so you aren't paying hot storage rates for cold FASTQ files.

·        Visby Security (FTR): The move to Diagnostics (Visby) brings HIPAA/GDPR into play. We run the Foundational Technical Review to ensure your new edge architecture is compliant before the first device goes live.

Next Step

 I wrote this because I want to see Watchmaker dominate the "Era of Biology" without getting weighed down by the "Era of Cloud Bills." Let's grab 15 mins to chat about the roadmap.